Challenges and management of childhood noninfectious chronic uveitis

References

• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509–516.
   PubMed Web of Science ®Google Scholar
• Classification criteria for birdshot chorioretinitis. Am J Ophthalmol. 2021;228:65–71. doi: 10.1016/j.ajo.2021.03.059.
   PubMed Web of Science ®Google Scholar
• Classification criteria for behçet disease uveitis. Am J Ophthalmol. 2021;228:80–88. doi: 10.1016/j.ajo.2021.03.058.
   PubMed Web of Science ®Google Scholar
• Classification criteria for cytomegalovirus anterior uveitis. Am J Ophthalmol. 2021;228:89–95. doi: 10.1016/j.ajo.2021.03.060.
   PubMed Web of Science ®Google Scholar
• Classification criteria for intermediate uveitis, non-pars planitis type. Am J Ophthalmol. 2021;228:159–164. doi: 10.1016/j.ajo.2021.03.054.
   PubMed Web of Science ®Google Scholar
• Classification criteria for multifocal choroiditis with panuveitis. Am J Ophthalmol. 2021;228:152–158. doi: 10.1016/j.ajo.2021.03.043.
   PubMed Web of Science ®Google Scholar
• Classification criteria for multiple sclerosis-associated intermediate uveitis. Am J Ophthalmol. 2021;228:72–79. doi: 10.1016/j.ajo.2021.03.044.
   PubMed Web of Science ®Google Scholar
• Classification criteria for pars planitis. Am J Ophthalmol. 2021;228:268–274. doi: 10.1016/j.ajo.2021.03.045.
   PubMed Web of Science ®Google Scholar
• Classification criteria for sarcoidosis-associated uveitis. Am J Ophthalmol. 2021;228:220–230. doi: 10.1016/j.ajo.2021.03.047.
   PubMed Web of Science ®Google Scholar
• Classification criteria for spondyloarthritis/HLA-B27-associated anterior uveitis. Am J Ophthalmol. 2021;228:117–125. doi: 10.1016/j.ajo.2021.03.049.
   PubMed Web of Science ®Google Scholar
• Classification criteria for syphilitic uveitis. Am J Ophthalmol. 2021;228:182–191. doi: 10.1016/j.ajo.2021.03.039.
   PubMed Web of Science ®Google Scholar
• Classification criteria for toxoplasmic retinitis. Am J Ophthalmol. 2021;228:134–141. doi: 10.1016/j.ajo.2021.03.042.
   PubMed Web of Science ®Google Scholar
• Classification criteria for tubercular uveitis. Am J Ophthalmol. 2021;228:142–151. doi: 10.1016/j.ajo.2021.03.040.
   PubMed Web of Science ®Google Scholar
• Classification criteria for vogt-koyanagi-harada disease. Am J Ophthalmol. 2021;228:205–211. doi: 10.1016/j.ajo.2021.03.036.
   PubMed Web of Science ®Google Scholar
• BenEzra D, Cohen E, Maftzir G. Uveitis in children and adolescents. Br J Ophthalmol. 2005;89:444–448.
   PubMed Web of Science ®Google Scholar
• Nagpal A, Leigh JF, Acharya NR. Epidemiology of uveitis in children. Int Ophthalmol Clin. 2008;48:1–7.
   PubMedGoogle Scholar
• Päivönsalo-Hietanen T, Tuominen J, Saari KM. Uveitis in children: population-based study in Finland. Acta Ophthalmologica Scandinavica. 2000;78:84–88.
   PubMedGoogle Scholar
• Shin Y, Kang J-M, Lee J, et al. Epidemiology of pediatric uveitis and associated systemic diseases. Pediatr Rheumatol Online J. 2021;19:48.
   PubMed Web of Science ®Google Scholar
• Maccora I, Sen ES, Ramanan AV. Update on noninfectious uveitis in children and its treatment. Curr Opin Rheumatol. 2020;32:395–402.
   PubMed Web of Science ®Google Scholar
• Chang MH, Shantha JG, Fondriest JJ, et al. Uveitis in children and adolescents. Rheum Dis Clin North Am. 2021;47:619–641.
   PubMed Web of Science ®Google Scholar
• Eser-Ozturk H, Sullu Y. Pediatric uveitis in a referral center in north part of Turkey. Ocul Immunol Inflamm. 2021;29:1299–1303.
   PubMed Web of Science ®Google Scholar
• Habot-Wilner Z, Tiosano L, Sanchez JM, et al. Demographic and clinical features of pediatric uveitis in Israel. Ocul Immunol Inflamm. 2020;28:43–53.
   PubMed Web of Science ®Google Scholar
• Gautam N, Singh R, Agarwal A, et al. Pattern of pediatric uveitis at a tertiary referral institute in North India. Ocul Immunol Inflamm. 2018;26:379–385.
   PubMed Web of Science ®Google Scholar
• Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet (London, England). 2007;369:767–778.
   PubMed Web of Science ®Google Scholar
• Angeles-Han ST, Ringold S, Beukelman T, et al. 2019 American College of Rheumatology/Arthritis foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis. Arthritis Rheumatol. 2019;71:864–877. .
   PubMed Web of Science ®Google Scholar
• Tolesa K, Abateneh A, Kempen JH, et al. Patterns of uveitis among patients attending jimma university department of ophthalmology, Jimma, Ethiopia. Ocul Immunol Inflamm. 2020;28:1109–1115.
   PubMed Web of Science ®Google Scholar
• Amin RM, Goweida M, Bedda A, et al. Clinical patterns and causes of intraocular inflammation in a uveitis patient cohort from Egypt. Ocul Immunol Inflamm. 2019;27:859–867.
   PubMed Web of Science ®Google Scholar
• Ganesh SK, Bala A, Biswas J, et al. Pattern of pediatric uveitis seen at a tertiary referral center from India. Ocul Immunol Inflamm. 2016;24:402–409.
   PubMed Web of Science ®Google Scholar
• Alzyoud R, Alsuwaiti M, Maittah H, et al. Pediatric noninfectious uveitis in a tertiary referral center in Jordan: clinical spectrum and immunomodulatory treatment. Cureus. 2022;14:e25841.
   PubMed Web of Science ®Google Scholar
• Abdelwareth Mohammed A, Soliman MM, Osman AA, et al. Patterns of uveitis in Egypt. Ocul Immunol Inflamm. 2021;29:1007–1016.
   PubMed Web of Science ®Google Scholar
• Hayworth JL, Turk MA, Nevskaya T, et al. The frequency of uveitis in patients with juvenile inflammatory rheumatic diseases. Joint Bone Spine. 2019;86:685–690.
   PubMed Web of Science ®Google Scholar
• Caspi RR. A look at autoimmunity and inflammation in the eye. J Clin Investig. 2010;120:3073–3083.
   PubMed Web of Science ®Google Scholar
• Akpek EK, Mathews P, Hahn S, et al. Ocular and systemic morbidity in a longitudinal cohort of Sjögren’s syndrome. Ophthalmol. 2015;122:56–61.
   PubMed Web of Science ®Google Scholar
• Bridges AJ, Burns RP. Acute iritis associated with primary Sjögren’s syndrome and high-titer anti-SS-A/ro and anti-SS-B/La antibodies. Treatment with combination immunosuppressive therapy. Arthritis Rheumatol. 1992;35:560–563.
   PubMed Web of Science ®Google Scholar
• Heaney A, McLoone E, Williams M, et al. Tubulointerstitial nephritis and uveitis in Northern Ireland. Eye (Lond). 2022;36:1645–1650.
   PubMed Web of Science ®Google Scholar
• Maccora I, Marrani E, Mastrolia MV, et al. Ocular involvement in monogenic autoinflammatory disease. Autoimmun Rev. 2021;20:102944. .
   PubMed Web of Science ®Google Scholar
• Maccora I, Maniscalco V, Marrani E, et al. Successful treatment of adalimumab in a child with Vogt-Koyanagi-Harada: which is the best available systemic treatment? Clin Exp Rheumatol. 2021;39:1453–1454.
   PubMed Web of Science ®Google Scholar
• Nigrovic PA, Lee PY, Hoffman HM. Monogenic autoinflammatory disorders: conceptual overview, phenotype, and clinical approach. J Allergy Clin Immunol. 2020;146:925–937.
   PubMed Web of Science ®Google Scholar
• Boyce TM, Whitmore SS, Varzavand K, et al. Long-term outcomes and risk factors for severe vision loss in Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy (ADNIV). Am J Ophthalmol. 2022;233:144–152. .
   PubMed Web of Science ®Google Scholar
• Li AS, Velez G, Darbro B, et al. Whole-exome sequencing of patients with posterior segment uveitis. Am J Ophthalmol. 2021;221:246–259. .
   PubMed Web of Science ®Google Scholar
• Kozycki CT, Kodati S, Huryn L, et al. Gain-of-function mutations in ALPK1 cause an NF-κB-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH syndrome. Ann Rheumatic Dis. 2022;81:1453–1464.
   PubMed Web of Science ®Google Scholar
• Huryn LA, Kozycki C, Serpen JY, et al. Ophthalmic manifestations of ROSAH (Retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and headache) syndrome, an inherited NF κB-Mediated autoinflammatory disease with retinal dystrophy. Ophthalmol. 2022;130(4):423–432. DOI:10.1016/j.ophtha.2022.10.026. .
   PubMed Web of Science ®Google Scholar
• Rothova A, Ooijman F, Kerkhoff F, et al. Uveitis masquerade syndromes. Ophthalmol. 2001;108:386–399.
   PubMed Web of Science ®Google Scholar
• Maleki A, Anesi SD, Look-Why S, et al. Pediatric uveitis: a comprehensive review. Surv Ophthalmol. 2022;67:510–529.
   PubMed Web of Science ®Google Scholar
• Chan N-W, Choi J, Cheung CMG. Pediatric Uveitis. Asia-Pac J Ophthalmol. 2018;7:192–199.
   PubMed Web of Science ®Google Scholar
• Haasnoot AM, Kuiper JJW, de Boer JH. Predicting uveitis in juvenile idiopathic arthritis: from biomarkers to clinical practice. Expert Rev Clin Immunol. 2019;15:657–666.
   PubMed Web of Science ®Google Scholar
• Yang P, Zhong Z, Su G, et al. RETINAL VASCULITIS, A COMMON MANIFESTATION OF IDIOPATHIC PEDIATRIC UVEITIS? Retina (Philadelphia, Pa.). Retina. 2021;41(3):610–619. DOI:10.1097/IAE.0000000000002885. .
   PubMed Web of Science ®Google Scholar
• Kempen JH, Ganesh SK, Sangwan VS, et al. Interobserver agreement in grading activity and site of inflammation in eyes of patients with uveitis. Am J Ophthalmol. 2008;146:813–8.e1.
   PubMed Web of Science ®Google Scholar
• Orès R, Terrada C, Errera M-H, et al. Laser flare photometry: a useful tool for monitoring patients with juvenile idiopathic arthritis-associated uveitis. Ocul Immunol Inflamm. 2022;30:118–128. .
   PubMed Web of Science ®Google Scholar
• Sharma S, Lowder CY, Vasanji A, et al. Automated analysis of anterior chamber inflammation by spectral-domain optical coherence tomography. Ophthalmol. 2015;122:1464–1470. doi: 10.1016/j.ophtha.2015.02.032.
   PubMed Web of Science ®Google Scholar
• Tsui E, Chen JL, Jackson NJ, et al. Quantification of anterior chamber cells in children with uveitis using anterior segment optical coherence tomography. Am J Ophthalmol. 2022;241:254–261. .
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Herbort CP. Laser flare photometry: a noninvasive, objective, and quantitative method to measure intraocular inflammation. Int Ophthalmol. 2010;30:453–464.
   PubMedGoogle Scholar
• Akbarali S, Rahi JS, Dick AD, et al. Imaging-based uveitis surveillance in juvenile idiopathic arthritis: feasibility, acceptability, and diagnostic performance. Arthritis Rheumatol. 2021;73:330–335. .
   PubMed Web of Science ®Google Scholar
• Keino H, Aman T, Furuya R, et al. Automated quantitative analysis of anterior segment inflammation using swept-source anterior segment optical coherence tomography: a pilot study. Diagn (Basel). 2022;12:2703. .
   PubMedGoogle Scholar
• Damsky W, Peterson D, Ramseier J, et al. The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases. J Allergy Clin Immunol. 2021;147:814–826.
   PubMed Web of Science ®Google Scholar
• Angeles-Han ST, Utz VM, Thornton S, et al. S100 proteins, cytokines, and chemokines as tear biomarkers in children with juvenile idiopathic arthritis-associated uveitis. Ocul Immunol Inflamm. 2021;29:1616–1620. .
   PubMed Web of Science ®Google Scholar
• Angeles-Han ST, Yeh S, Patel P, et al. Discovery of tear biomarkers in children with chronic non-infectious anterior uveitis: a pilot study. J Ophthalmic Inflamm Infect. 2018;8(1):17.
   PubMed Web of Science ®Google Scholar
• Kalinina Ayuso V, de Boer JH, Byers HL, et al. Intraocular biomarker identification in uveitis associated with juvenile idiopathic arthritis. Invest Ophthalmol Visual Sci. 2013;54:3709–3720.
   PubMed Web of Science ®Google Scholar
• Maggi L, Mazzoni A, Cimaz R, et al. Th17 and Th1 lymphocytes in oligoarticular juvenile idiopathic arthritis. Front Immunol. 2019;10:450.
   PubMed Web of Science ®Google Scholar
• Walscheid K, Neekamp L, Heiligenhaus A, et al. Increased circulating proinflammatory T lymphocytes in children with different forms of anterior uveitis: results from a pilot study. Ocul Immunol Inflamm. 2019;27:788–797.
   PubMed Web of Science ®Google Scholar
• Bansal R, Gupta A. Protein Biomarkers in Uveitis. Front Immunol. 2020;11:610428.
   PubMed Web of Science ®Google Scholar
• Bonacini M, Soriano A, Cimino L, et al. Cytokine profiling in aqueous humor samples from patients with non-infectious uveitis associated with systemic inflammatory diseases. Front Immunol. 2020;11:358.
   PubMed Web of Science ®Google Scholar
• El-Asrar AMA, Al-Obeidan SS, Kangave D, et al. CXC chemokine expression profiles in aqueous humor of patients with different clinical entities of endogenous uveitis. Immunobiology. 2011;216:1004–1009.
   PubMed Web of Science ®Google Scholar
• El-Asrar AMA, Berghmans N, Al-Obeidan SA, et al. Differential CXC and CX3C chemokine expression profiles in aqueous humor of patients with specific endogenous uveitic entities. Invest Ophthalmol Visual Sci. 2018;59:2222–2228. .
   PubMed Web of Science ®Google Scholar
• Wildschütz L, Ackermann D, Witten A, et al. Transcriptomic and proteomic analysis of iris tissue and aqueous humor in juvenile idiopathic arthritis-associated uveitis. J Autoimmun. 2019;100:75–83.
   PubMed Web of Science ®Google Scholar
• Hou S, Li N, Liao X, et al. Uveitis genetics. Exp Eye Res. 2020;190:107853.
   PubMed Web of Science ®Google Scholar
• de Silvestri A, Capittini C, Poddighe D, et al. HLA-DRB1 alleles and juvenile idiopathic arthritis: diagnostic clues emerging from a meta-analysis. Autoimmun Rev. 2017;16:1230–1236.
   PubMed Web of Science ®Google Scholar
• Haasnoot AM, Schilham MW, Kamphuis S, et al. Identification of an amino acid motif in HLA-DRβ1 that distinguishes uveitis in patients with juvenile idiopathic arthritis. Arthritis Rheumatol. 2018;70:1155–1165. .
   PubMed Web of Science ®Google Scholar
• Pers Y-M, Le Blay P, Ludwig C, et al. Association of TRAF1-C5 with risk of uveitis in juvenile idiopathic arthritis. Joint Bone Spine. 2017;84:305–308. .
   PubMed Web of Science ®Google Scholar
• Pang T, Du L, Li F, et al. Association of apoptosis genes in PDCD1 but not PDCD1LG2, FAS, and FASLG with pediatric idiopathic uveitis in Han Chinese. Pediat Res. 2020;87:634–638. .
   PubMed Web of Science ®Google Scholar
• Lv M, Tan H, Deng J, et al. Association of toll-like receptor 10 polymorphisms with paediatric idiopathic uveitis in Han Chinese. Br J Ophthalmol. 2020;104:1467–1471.
   PubMed Web of Science ®Google Scholar
• Ortiz-Fernández L, Carmona FD, Montes-Cano MA, et al. Genetic analysis with the immunochip platform in behçet disease. Identification of residues associated in the HLA class i region and new susceptibility loci. PLoS ONE. 2016;11:e0161305.
   PubMed Web of Science ®Google Scholar
• Ortiz-Fernández L, García-Lozano J-R, Montes-Cano M-A, et al. Association of haplotypes of the TLR8 locus with susceptibility to Crohn’s and Behçet’s diseases. Clin Exp Rheumatol. 2015;33:S117–22.
   PubMed Web of Science ®Google Scholar
• Burillo-Sanz S, Montes-Cano M-A, García-Lozano J-R, et al. Mutational profile of rare variants in inflammasome-related genes in Behçet disease: a next generation sequencing approach. Sci Rep. 2017;7:8453.
   PubMedGoogle Scholar
• Wouters CH, Maes A, Foley KP, et al. Blau syndrome, the prototypic auto-inflammatory granulomatous disease. Pediatr Rheumatol Online J. 2014;12(33). DOI:10.1186/1546-0096-12-33
   PubMedGoogle Scholar
• Haasnoot AJW, van Tent-Hoeve M, Wulffraat NM, et al. Erythrocyte sedimentation rate as baseline predictor for the development of uveitis in children with juvenile idiopathic arthritis. Am J Ophthalmol. 2015;159:372–7.e1.
   PubMed Web of Science ®Google Scholar
• Nordal E, Rypdal V, Christoffersen T, et al. Incidence and predictors of Uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study. Pediatr Rheumatol Online J. 2017;15(66). doi:10.1186/s12969-017-0195-8.
   Google Scholar
• Walscheid K, Heiligenhaus A, Holzinger D, et al. Elevated S100A8/A9 and S100A12 serum levels reflect intraocular inflammation in juvenile idiopathic arthritis-associated uveitis: results from a pilot study. Invest Ophthalmol Visual Sci. 2015;56:7653–7660. .
   PubMed Web of Science ®Google Scholar
• Tappeiner C, Klotsche J, Sengler C, et al. Risk factors and biomarkers for the occurrence of uveitis in juvenile idiopathic arthritis: data from the inception cohort of newly diagnosed patients with juvenile idiopathic arthritis study. Arthritis Rheumatol. 2018;70:1685–1694.
   PubMed Web of Science ®Google Scholar
• Lee JJY, Duffy CM, Guzman J, et al. Prospective determination of the incidence and risk factors of new-onset uveitis in juvenile idiopathic arthritis: the research in arthritis in Canadian children emphasizing outcomes cohort. Arthritis Care Res. 2019;71:1436–1443.
   Web of Science ®Google Scholar
• Heiligenhaus A, Klotsche J, Tappeiner C, et al. Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study. Rheumatology. 2019;58:975–986. .
   PubMed Web of Science ®Google Scholar
• Clarke SLN, Mageean KS, Carlton H, et al. Environmental risk factors associated with juvenile idiopathic arthritis associated uveitis: a systematic review of the literature. J Ophthalmic Inflamm Infect. 2021;11:15.
   PubMed Web of Science ®Google Scholar
• Davies R, de Cock D, Kearsley-Fleet L, et al. The risk of uveitis in patients with JIA receiving etanercept: the challenges of analysing real-world data. Rheumatology. 2020;59:1391–1397.
   PubMed Web of Science ®Google Scholar
• Armaroli G, Klein A, Ganser G, et al. Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry. Arthritis Res Ther. 2020;22:258.
   PubMed Web of Science ®Google Scholar
• Simonini G, Bracaglia C, Cattalini M, et al. Predictors of relapse after discontinuing systemic treatment in childhood autoimmune chronic uveitis. J Rheumatol. 2017;44:822–826. .
   PubMed Web of Science ®Google Scholar
• Kumar A, Sharma SP, Agarwal A, et al. Tear IL-6 and IL-10 levels in HLA-B27-associated uveitis and its clinical implications. Ocul Immunol Inflamm. 2021;29:237–243.
   PubMed Web of Science ®Google Scholar
• García-Onrubia L, Mateos Olivares M, García-Vázquez C, et al. Tear and plasma levels of cytokines in patients with uveitis: search for active disease biomarkers. J Clin Med. 2022;11:7034.
   PubMed Web of Science ®Google Scholar
• Carreño E, Portero A, Herreras JM, et al. Cytokine and chemokine tear levels in patients with uveitis. Acta Ophthalmol. 2017;95:e405–414.
   PubMed Web of Science ®Google Scholar
• Gerss J, Roth J, Holzinger D, et al. Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study. Ann Rheumatic Dis. 2012;71:1991–1997.
   PubMed Web of Science ®Google Scholar
• Ganeva M, Fuehner S, Kessel C, et al. Trajectories of disease courses in the inception cohort of newly diagnosed patients with JIA (ICON-JIA): the potential of serum biomarkers at baseline. Pediatr Rheumatol. 2021;19. DOI:10.1186/s12969-021-00553-x.
   PubMed Web of Science ®Google Scholar
• Simonini G, Paudyal P, Jones GT, et al. Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach. Rheumatology. 2013;52:825–831.
   PubMed Web of Science ®Google Scholar
• Tirelli F, Zannin ME, Vittadello F, et al. Methotrexate monotherapy in juvenile idiopathic arthritis associated uveitis: myth or reality? Ocul Immunol Inflamm. 2021;30:1–5.
   Web of Science ®Google Scholar
• Anglade E, Yatscoff R, Foster R, et al. Next-generation calcineurin inhibitors for ophthalmic indications. Expert Opin Investig Drugs. 2007;16:1525–1540.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130:492–513.
   PubMed Web of Science ®Google Scholar
• Simonini G, Cantarini L, Bresci C, et al. Current therapeutic approaches to autoimmune chronic uveitis in children. Autoimmun Rev. 2010;9:674–683.
   PubMed Web of Science ®Google Scholar
• Maccora I, Fusco E, Marrani E, et al. Changing evidence over time: updated meta-analysis regarding anti-TNF efficacy in childhood chronic uveitis. Rheumatology. 2021;60(2):568–587. DOI:10.1093/rheumatology/keaa595. .
   PubMed Web of Science ®Google Scholar
• Ramanan AV, Dick AD, Jones AP, et al. Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis. N Engl J Med. 2017;376:1637–1646. .
   PubMed Web of Science ®Google Scholar
• Quartier P, Baptiste A, Despert V, et al. ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis. Annals of the rheumatic diseases. Ann Rheumatic Dis. 2018;77(7):1003–1011. DOI:10.1136/annrheumdis-2017-212089. .
   PubMed Web of Science ®Google Scholar
• Simonini G, Taddio A, Cattalini M, et al. Prevention of flare recurrences in childhood-refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab. Arthritis Care Res. 2011;63:612–618.
   PubMed Web of Science ®Google Scholar
• Maccora I, Abu Rumeileh S, Curci F, et al. Tocilizumab and abatacept for the treatment of childhood chronic uveitis: a monocentric comparison experience. Front Pediatr. 2022;10:851453. .
   PubMed Web of Science ®Google Scholar
• Maccora I, Dell’anna MP, Vannacci A, et al. Safety evaluations of adalimumab for childhood chronic rheumatic diseases. Expert Opin Drug Saf. 2020;19:661–671.
   PubMed Web of Science ®Google Scholar
• Atienza-Mateo B, Martín-Varillas JL, Calvo-Río V, et al. Comparative Study of infliximab versus adalimumab in refractory uveitis due to behçet’s disease: national multicenter study of 177 Cases. Arthritis Rheumatol. 2019;71:2081–2089.
   PubMed Web of Science ®Google Scholar
• Ramanan AV, Dick AD, Guly C, et al. Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial. Lancet Rheumatol. 2020;2:e135–141. .
   PubMedGoogle Scholar
• Wennink RAW, Ayuso VK, de Vries LA, et al. Tocilizumab as an effective treatment option in children with refractory intermediate and panuveitis. Ocul Immunol Inflamm. 2021;29:21–25.
   PubMed Web of Science ®Google Scholar
• Miraldi Utz V, Angeles-Han ST, Mwase N, et al. Alternative biologic therapy in children failing conventional TNFα Inhibitors for refractory, noninfectious, chronic anterior uveitis. Am J Ophthalmol. 2022;244:183–195.
   PubMed Web of Science ®Google Scholar
• Dipasquale V, Atteritano M, Fresta J, et al. Tocilizumab for refractory uveitis associated with juvenile idiopathic arthritis: a report of two cases. J Clin Pharm Therapeutics. 2019;44:482–485.
   PubMed Web of Science ®Google Scholar
• Tappeiner C, Mesquida M, Adán A, et al. Evidence for tocilizumab as a treatment option in refractory uveitis associated with juvenile idiopathic arthritis. J Rheumatol. 2016;43:2183–2188.
   PubMed Web of Science ®Google Scholar
• Calvo-Río V, Santos-Gómez M, Calvo I, et al. Anti-interleukin-6 receptor tocilizumab for severe juvenile idiopathic arthritis-associated uveitis refractory to anti-tumor necrosis factor therapy: a multicenter study of twenty-five patients. Arthritis Rheumatol. 2017 69; 69(3):668–675. doi: 10.1002/art.39940.
   PubMed Web of Science ®Google Scholar
• Barroso-García N, Atienza-Mateo B, Ferraz-Amaro I, et al. Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet’s disease. Multicenter study of 49 patients. Semin Arthritis Rheum. 2023;58:152153.
   PubMed Web of Science ®Google Scholar
• Marrani E, Paganelli V, de Libero C, et al. Long-term efficacy of abatacept in pediatric patients with idiopathic uveitis: a case series. Graefe’s Arch Clin Exp Ophthalmol. 2015;253:1813–1816.
   PubMed Web of Science ®Google Scholar
• Tappeiner C, Miserocchi E, Bodaghi B, et al. Abatacept in the treatment of severe, longstanding, and refractory uveitis associated with juvenile idiopathic arthritis. J Rheumatol. 2015;42:706–711.
   PubMed Web of Science ®Google Scholar
• Miserocchi E, Modorati G, Berchicci L, et al. Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis. Br J Ophthalmol. 2016;100:782–786.
   PubMed Web of Science ®Google Scholar
• Miserocchi E, Giuffrè C, Cornalba M, et al. JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis. Clin Rheumatol. 2020;39:847–851. doi: 10.1007/s10067-019-04875-w.
   PubMed Web of Science ®Google Scholar
• Zhao N, Tang Y, Wang S, et al. Case report: refractory intestinal Behçet’s syndrome successfully treated with tofacitinib: a report of four cases. Front Immunol. 2022;13:981502.
   PubMed Web of Science ®Google Scholar
• Wen J, Hu H, Chen M, et al. Role of Janus Kinase (JAK) inhibitor in autoimmune ocular inflammation: a systematic review. J Immunol Res. 2021;2021:2324400.
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Murakami T, Nishitsuka K, et al. Effectiveness of baricitinib in refractory seronegative rheumatoid arthritis and uveitis: a case report. Front Med. 2021;8:764067.
   Web of Science ®Google Scholar
• Bauermann P, Heiligenhaus A, Heinz C. Effect of janus kinase inhibitor treatment on anterior uveitis and associated macular edema in an adult patient with juvenile idiopathic arthritis. Ocul Immunol Inflamm. 2019;27:1232–1234.
   PubMed Web of Science ®Google Scholar
• Ruperto N, Brunner HI, Synoverska O, et al. Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial. Lancet (London, England). 2021;398:1984–1996. .
   PubMed Web of Science ®Google Scholar
• Ramanan AV, Guly CM, Keller SY, et al. Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT). Trials. 2021;22:689. .
   PubMed Web of Science ®Google Scholar
• Foeldvari I, Maccora I, Petrushkin H, et al. New and updated recommendations for the treatment of juvenile idiopathic arthritis associated uveitis and idiopathic chronic anterior uveitis. Arthritis Care Res. 2022. doi: 10.1002/acr.24963.
   Web of Science ®Google Scholar
• Constantin T, Foeldvari I, Anton J, et al. Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative. Ann Rheumatic Dis. 2018;77:1107–1117.
   PubMed Web of Science ®Google Scholar
• Kimura Y, Schanberg LE, Tomlinson GA, et al. Optimizing the start time of biologics in polyarticular juvenile idiopathic arthritis: a comparative effectiveness study of childhood arthritis and rheumatology research alliance consensus treatment plans. Arthritis Rheumatol. 2021;73:1898–1909. .
   PubMed Web of Science ®Google Scholar
• Ong MS, Ringold S, Kimura Y, et al. Improved disease course associated with early initiation of biologics in polyarticular juvenile idiopathic arthritis: trajectory analysis of a childhood arthritis and rheumatology research alliance consensus treatment plans study. Arthritis Rheumatol. 2021;73:1910–1920.
   PubMed Web of Science ®Google Scholar
• Halyabar O, Mehta J, Ringold S, et al. Treatment withdrawal following remission in juvenile idiopathic arthritis: a systematic review of the literature. Paediatr Drugs. 2019;21:469–492.
   PubMed Web of Science ®Google Scholar
• Liebling EJ, Faig W, Chang JC, et al. Temporal relationship between juvenile idiopathic arthritis disease activity and uveitis disease activity. Arthritis Care Res. 2022;74:349–354.
   Web of Science ®Google Scholar
• Acharya NR, Ebert CD, Kelly NK, et al. Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST-Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial. Trials. 2020;21:887.
   PubMed Web of Science ®Google Scholar
• Simonini G, Ferrara G, Pontikaki I, et al. Flares after withdrawal of biologic therapies in juvenile idiopathic arthritis: clinical and laboratory correlates of remission duration. Arthritis Care Res. 2018;70:1046–1051.
   PubMed Web of Science ®Google Scholar
• Martín-Varillas JL, Atienza-Mateo B, Calvo-Rio V, et al. Long-term follow-up and optimization of infliximab in refractory uveitis due to behçet disease: national study of 103 white patients. J Rheumatol. 2021;48:741–750.
   PubMed Web of Science ®Google Scholar
• Ozer MD, Batur M. Anti-tumor necrosis factor-alpha treatment in pediatric patients with pars planitis: a single-center experience from Turkey. Int Ophthalmol. 2023;43:155–166.
   PubMed Web of Science ®Google Scholar
• Maccora I, Guly C, de Libero C, et al. Childhood chronic idiopathic uveitis in a multicentre international cohort. Ocul Immunol Inflamm. 2023;1–10. DOI:10.1080/09273948.2023.2169715
   PubMed Web of Science ®Google Scholar
• Cann M, Ramanan AV, Crawford A, et al. Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy. Pediatr Rheumatol Online J. 2018;16:51.
   PubMed Web of Science ®Google Scholar